Table 5.

Competing risk-adjusted Models for revision risk adjusting for risk of death

	Hazards of THA Revision (95 % CI)	P-value*	Hazards of THA Revision (95 % CI)	P-value*
	2-year data		5-year data
	N = 3151 with 88 events		N = 2461 with 71 events
Harris Hip Score categories
≤ 55 vs. 81–100	3.90 (2.67,5.69)	< 0.001	2.48 (1.56,3.95)	< 0.001
56–63 vs. 81–100	2.24 (1.45,3.46)	< 0.001	2.04 (1.25,3.32)	< 0.001
64–71 vs. 81–100	2.36 (1.60,3.49)	< 0.001	2.78 (1.72,4.48)	< 0.001
72–80 vs. 81–100	2.18 (1.61,2.94)	< 0.001	2.43 (1.70,3.460	< 0.001
Harris Hip Score clinical categories
< 70 vs. 90–100	3.40 (2.59,4.45)	< 0.001	2.65 (1.92,3.66)	< 0.001
70–79 vs. 90–100	2.66 (1.92,3.68)	< 0.001	2.88 (1.96,4.25)	< 0.001
80–89 vs. 90–100	2.02 (159,2.57)	< 0.001	1.64 (1.21,2.24)	< 0.001
	N = 1011 with 13 events		N = 583 with 5 events
Improvements in Harris Hip Score
≤ 0 vs. 51–75	2.48 (1.00,6.14)	0.05	2.30 (0.46,11.61)	0.31
1–20 vs. 51–75	0.99 (0.38,2.57)	0.98	1.97 (0.63,6.15)	0.24
21–50 vs. 51–75	0.68 (0.40,1.15)	0.15	0.92 (0.42,2.02)	0.84